Last updated: 2026-09-09 18:15:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Clene Inc. (CLNN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.60, with a market capitalization of $49.47M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.51 to $13.50. This page covers its latest market performance, valuation, price trends and company information.
$49.47M | |
$3.67 | |
$356.40 | |
$2.28 | |
$3.62 | |
127.70K | |
83.03K | |
-- | |
$13.50 | |
$3.51 | |
-- | |
-- |
Clene Inc. (CLNN) is currently trading at $3.60 as of 2026-09-09 17:58:46, down 0.44% ($0.02) from the previous close of $3.62
During today's regular trading session, CLNN has traded between $2.28 and $356.40, with a trading volume of 127.70K shares. The current price is near the lower end of today's range.
Over the past seven days, Clene Inc. (CLNN) moved from $4.23 to $3.60, representing a decline of 14.80% ($0.63).
The stock traded between $3.51 and $4.74 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 126.92 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 1.0%
CLNN is currently trading at $3.60, placing it 1.0% of the way from its 52-week low of $3.51 to its 52-week high of $13.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 79 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Clene Inc. (CLNN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.